With the global gummy supplement category projected to more than double in size by 2030 to US $52.2 billion[i] and nearly two-thirds of U.S adults now favor gummies over tablets[ii] Jungbunzlauer’s offer reflects the shifting preferences shaping this rapidly expanding category.
